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Stimuli-responsive nanogels offer promising perspectives for the development of next generation 
formulations for biomedical applications. In this work, poly(N-vinylcaprolactam) nanogels were 
synthesized varying the concentration of monomer and crosslinking agent. Thus, the inhibitory effect of 
poly(N-vinylcaprolactam) nanogels against HIV-1 infection is presented for the first time. In particular, 
we have demonstrated that one of the synthesized poly(N-vinylcaprolactam) nanogels with initial 
concentration of 80 mg of vinylcaprolactam and 4% of crosslinking agent shows antiviral behavior 
against HIV-1 infection since this nanogel inhibits the viral replication in TZM.bl target cells.
The Joint United Nations Program on HIV/AIDS (UNAIDS) estimates that approximately 37 million people were 
living with HIV-1 worldwide at the end of 20161,2. In addition, HIV-1 sexual transmission is held accountable for 
around 80% of all infections, with roughly half of the affected individuals being women3. In the last years, the use 
of long-lasting, female-controlled and efficacious topical microbicides to decrease and control HIV-1 epidemic 
among women has strongly emerged4–7.
Many compounds with anti-HIV-1 activity have been tested as topical microbicides, such as sulfated poly-
saccharides like carrageenan and dextran sulfated8,9, drugs like tenofovir10–12 or dapivirine13, and nanostructures 
like dendrimers14–16. However, most of them have failed in the clinical trials due to vaginal toxicity and irritation, 
increasing the susceptibility to sexually transmitted infections rather than providing protection17,18. Recently, 
a patent in which hypotonic formulations of synthetic hydrogel based on poloxamer were used as vaginal or 
colorectum mucosal barriers was published19. Its ability for trapping viruses including HIV was demonstrated. 
This work constitutes, to the best of our knowledge, the only report of the use of synthetic polymeric hydrogels 
as anti-HIV agents by themselves. However, the development of polymeric formulations with low polydispersity 
values and a well-defined molecular weight results challenging. In this sense, nanogels (NGs) have emerged as 
sized-controlled nanostructures with important biomedical applications. NGs are three-dimensional-crosslinked 
polymeric matrices that have nanometric sizes in their three dimensions20. NGs combine the solids and fluids 
properties, and some of their properties depend on the contributions of each portion21. The liquid presence pre-
vents the network from collapsing into an insoluble compact mass and the solid part prevents the liquid from 
flowing freely.
NGs have unique properties, such as, high encapsulation efficiency and protection of active agents from deg-
radation, which make them ideal candidates as drug delivery or theranostic systems. In addition, the hydrophilic 
nature of NGs gives high biocompatibility, which represents a clear advantage over other types of nanomaterials 
in this kind of applications22. In other words, unique multifunctionality and stability of NGs are difficult to find 
in other types of nanosystems23,24. For example, inorganic nanomaterials such as quantum dots and magnetic and 
1Universidad nacional de córdoba, facultad de ciencias Químicas, Departamento de Química Orgánica. Av. Haya de 
la Torre esq. Av. Medina Allende, Córdoba, X5000HUA, Argentina. 2cOnicet, instituto de investigación y Desarrollo 
en Ingeniería de Procesos y Química Aplicada (IPQA). Av. Velez Sárfield 1611, Córdoba, X5000HUA, Argentina. 
3Sección inmunología, Laboratorio inmuno Biología Molecular, Hospital General Universitario Gregorio Marañón, 
Madrid, 28007, Spain. 4Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, 28007, Spain. 
5Spanish HIV HGM Biobank, Madrid, 28007, Spain. 6networking Research center on Bioengineering, Biomaterials 
and Nanomedicine (CIBER-BBN), Madrid, 28029, Spain. Micaela A. Macchione, Carlos Guerrero-Beltrán and Anabella 
P. Rosso contributed equally. correspondence and requests for materials should be addressed to M.c.S. (email: 
mcs@fcq.unc.edu.ar) or M.Á.M.-F. (email: mmunoz.hgugm@salud.madrid.org)
Received: 5 October 2018
Accepted: 18 March 2019
Published: xx xx xxxx
opeN
2Scientific RepoRts |          (2019) 9:5732  | https://doi.org/10.1038/s41598-019-42150-9
www.nature.com/scientificreportswww.nature.com/scientificreports/
gold nanoparticles, that have numerous applications, including against sexual infection diseases (SIDs), have low 
colloidal stability and are rapidly eliminated by the mononuclear phagocytic system22.
Moreover, stimuli-responsive NGs respond to external stimuli (pH, temperature, magnetic field, redox envi-
ronments, among others)25. These smart materials offer new promising perspectives for the development of next 
generation therapeutic agents. Considering all the stimuli-responsive systems, poly(N-vinylcaprolactam) (PVCL) 
is one of the most studied thermo-responsive polymers26–30, after poly(N-isopropylacrylamide) (PNIPAm)26. 
Recent studies have reported that PVCL is biocompatible, and then it is very attractive for biomedical and envi-
ronmental applications26. Also, the possible hydrolysis of amide group of VCL will produce a polymeric carbox-
ylic acid, which is innocuous for biomedical applications. On the contrary, PNIPAm can yieldsmall toxic amide 
compound31. However, deeper studies on the synthesis, functionalization, characterization and applications of 
PVCL-based NGs are required.
PVCL displays a thermo-responsive behavior, with a characteristic lower critical solution temperature (LCST). 
Accordingly, below LCST the polymer swells in water and after heating, it shrinks rapidly to a collapsed state32. 
It has been found that for PVCL hydrogels the swelling-collapse behavior is completely reversible with the same 
LCST for both processes, between 30 and 32 °C26,33.
NGs have not been tested previously as antiviral agent for inhibition of HIV-1 infection. In this context, we 
present, for the first time, the effect of NGs against the HIV-1 infection. Particularly, we have demonstrated that a 
PVCL NG with initial concentration of 80 mg of VCL and 4% of crosslinking agent (PVCL804 NG) can be consid-
ered as new potential microbicide against the HIV-1 infection since the PVCL804 NG inhibits the viral replication 
in TZM.bl target cells.
Experimental Section
Reagents. N-Vinylcaprolactam (VCL) was obtained from Aldrich; N,N′-methylenebisacrylamide (BIS) 
(99%) from Sigma-Aldrich; N,N,N′,N′ tetramethylethylenediamine (TEMED) (98%) from Fluka; potas-
sium persulfate (KPS) from Merck; sodium dodecyl sulfate (SDS) (96%) from BioPack; 3-(4,5-dimethylthi-
azol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) from Sigma-Aldrich; dimethyl sulfoxide (DMSO) from 
Sigma-Aldrich; nuclease-free water from Promega, Madrid, Spain; phosphate-buffered saline (PBS) from Lonza, 
Walkersville, MD, USA; Dulbecco’s Modified Eagle’s Medium (DMEM) from Biochrom, AG, Germany; supple-
mented with 5% heat-inactivated-fetal bovine serum from Life Technologies, Madrid, Spain and a cocktail of 
antibiotics. Dialysis membranes of cellulose ester with a molecular weight cut-off of 50 kDa were purchased from 
SpectrumLabs. All chemicals were used as purchased. MilliQ grade water was employed as the polymerization 
medium.
Synthesis of nanogels. PVCL NGs were prepared by thermo-precipitation in aqueous phase via free rad-
ical polymerization as follows: appropriate amounts of VCL and crosslinker (BIS) and, 0.0013 g of SDS (between 
0.8–1.0%), were added to 3 mL MilliQ grade water. The solution was purged with nitrogen for 15 min under 
continuous stirring to remove dissolved oxygen. The reaction was carried out at 70 °C for about 5 h after the addi-
tion of 1% mol of KPS and 1% mol TEMED to initiate the polymerization by thermal decomposition. After the 
reaction, the NGs were purified by dialysis with membranes of cellulose ester with a molecular weight cut-off of 
50 kDa against distilled water (2 liters) for one week (1 change of water per day) to remove unreacted monomers 
and the surfactant. Subsequently, for biological assays the samples were freeze-dryed obtaining a white solid.
The following NGs were obtained: PVCL800, PVCL801, PVCL802, PVCL804, PVCL600, PVCL604 and 
PVCL6010. They were called according to their composition as PVCLxy, where x means mg of VCL and y mol 
percentage of BIS respect to mols of VCL.
spectroscopic analysis. Fourier transform infrared spectra (FT-IR) bands of the lyophilized NGs were 
obtained on a Nicolet iN10 (Thermo Scientific, USA; ST 2425-CONICET) using a liquid nitrogen cooled detector 
of Mercury Cadmium Tellurium (MCT). Data were analyzed using the OMNIC 8.3 Picta software package.
Nuclear magnetic resonance spectra were recorded on a Bruker Ultra Shield 400 (1H-NMR: 400 MHz ST 
1027-CONICET) in deuterated water. Data were analyzed using the Mestre Nova software package.
Average particle diameter and phase transition temperature. Average hydrodynamic particle 
diameter (Dh) at different temperatures and the phase transition temperatures (Tp), were determined by dynamic 
light scattering (DLS) in a Nano Zetasizer instrument with a He–Ne laser (λ = 633 nm) and scattering angle of 
173°. Measurements were made in a temperature range from 15 °C to 50 °C with a temperature equilibrium time 
of 120 s. All samples were prepared with a dilution of 1 in 10.
Cloud point temperatures (Tcp) were measured on a Shimadzu 1800 UV-vis spectrophotometer. Suspensions 
of NGs were heated from 15 to 50 °C while monitoring every 2 °C both the transmittance at 600 nm (1 cm path 
length) and the solution temperature. The Tcp of each NG was determined using the inflection point of the curve 
of the absorbance vs. temperature.
thermogravimetric Analysis (tGA). Thermal degradation curves of NGs were performed on a Shimadzu 
DTG-60 (Japan) (ST 2901-CONICET), measurements were carried out from room temperature to 800 °C at a 
heating rate of 10 °C/min under a pure nitrogen atmosphere.
Size and morphology of nanogels. Transmission electron microscopy (TEM) observations were carried 
out on a JEOL JEM EXII 1200 of high contrast, operating with 80 kV (INTI-IPAVE-CONICET). Samples were 
prepared on carbon-coated copper grids of 200 mesh from TED PELLA. The solution of each NG was dripped on 
a grid and left to dry at room temperature. Then, they were covered with a 2% uranyl acetate solution and again 
allowed to dry at room temperature.
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The size distribution determined from TEM images was performed by using Image J software. Average diam-
eter values were obtained from populations of 200 particles.
Cell viability assays. PVCL NGs toxicity was determined on TZM.bl cell line by MTT assay according to 
the manufacturer’s instructions by using a Synergy 4 Plate Multileaver, Biotek Instrument (USA). A stock suspen-
sion of NGs (in order to give 100 µg/mL in the experiment) was prepared by weighing the white solid obtained 
after freeze-drying and mixing it with nuclease-free water. Then, this sample was sonicated by 15 min to obtain 
a stable suspension. Lower-concentration suspensions were prepared by dilution of this stock suspension using 
nuclease-free water. DMSO (10%) and culture medium were used as positive and negative controls of cellular 
death, respectively. Each experiment was performed in triplicate.
Inhibition of HIV-1 replication experiments. Cells were seeded in p96-well plates 24 h prior to exper-
iments (15 × 103cells/well). TZM.bl cells were treated with non-toxic concentrations of PVCL NG for 1 h before 
infection with R5-HIV-1NLAD8 isolate (30 ng of p24/106cells) under culture conditions. After 3 h, cells were washed 
twice with sterile phosphate-buffered saline (PBS) and incubated for 48 h at 37 °C and 5% CO2. Cells were lysed 
and the percentage of HIV-1 infection was determined by quantification of luciferase activity (Luciferase Assay 
System, Promega). G2-S16 dendrimer (10 µM) was used as a positive control of HIV-1 inhibition34,35. Each exper-
iment was performed in triplicate.
Results and Discussion
In this work, a series of NGs from VCL were prepared by thermo-precipitation in aqueous phase in the presence 
of a surfactant (SDS) to control the size and reduce the distribution of the particles (Fig. 1). The polymerization 
was carried out at 70 °C, a temperature above the LCST of PVCL, and the reaction begins with a thermal initiator 
(KPS). When the chain length of the oligomers grows, their solubility in water decreases and the previous homo-
geneous systems becomes heterogeneous with particles that form a dispersed phase. Within the dispersed phase, 
the particles grow as the polymerization continues until the so-called “critical length” in which the polymeriza-
tion is stopped. The reaction was initiated via free radical polymerization by the thermo-initiator KPS/TEMED. 
The polymeric NGs were synthesized by varying monomer and crosslinker ratios. NGs were purified through 
dialysis against water and obtained as a white solid after freeze-drying.
spectroscopic analysis. In order to confirm the polymerization of VCL and the crosslinking with BIS, 
FT-IR and 1H-NMR spectroscopy measurements were carried out. Figure 2 shows FT-IR spectra corresponding 
to VCL and NGs. The FT-IR spectrum of the PVCL (without crosslinker) exhibited the characteristics bands 
at 2900–3000, 1631, and 1479 cm−1 corresponding to the stretching vibration of the C-H, C=O, and C-N, 
respectively36.
On the other hand, the FT-IR spectrum of the crosslinked NGs with BIS also showed a signal at 1530 cm−1 
corresponding to the deformation of the N-H (amide group) and it was clearly observed that the relative intensity 
of this signal increased with the amount of crosslinker. The 1H-NMR spectrum of the monomer VCL exhibited 
the peaks at 7.2, 4.8 and 4.6 ppm (1H each, =CH) corresponding to the vinyl protons, and the peaks at 3.7, 2.6 
(2H each, –CH2) and 1.7 ppm (6H, −CH2) corresponding to the caprolactam ring37. Regarding at the 1H-NMR 
spectra of the PVCL NGs was possible to observe the typical widening of bands as well as the disappearance of 
the signals coming from the vinyl protons. These facts confirm the polymerization reaction and the absence of 
free monomer (Fig. 3).
Average particle diameter and phase transition temperature. A large number of variables influ-
ence the nanostructure of the NGs and their thermo-responsive behavior, such as type of solvent, concentration of 
Figure 1. Series of NGs from PVCL prepared by thermo-precipitation in aqueous phase.
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polymer, degree of crosslinking and ionization, among others30. In order to evaluate structure and thermo-responsive 
behavior, a series of NGs were synthesized.
The swelling/thermal behaviors of the NGs obtained by DLS are shown in Fig. 4. All the NGs are sized within 
the nanometric scale when the temperature of the medium is below LCST with a polydispersity index (PDI) val-
ues between 0.2 and 0.4. In most of the systems, the response of the NGs to the temperature leads to an increase in 
average size indicating the aggregation of the particles. However, the PVCL804 NG is the only one which displays 
collapse without aggregation when increasing the temperature. When considering both set of experiments per-
formed using different initial amount of VCL, a clear trend can be observed: as the BIS concentration increases, 
the degree of aggregation observed after the Tp decreases (Fig. 4). This behavior could be attributed to stronger 
intra-molecular interactions present in these experimental conditions.
The average hydrodynamic diameters were determined below Tcp (Table 1). For the same initial VCL con-
centration, a Dh value increase was observed as a consequence of the increment of the crosslinker amount 
(BIS). Forcada et al.38,39 have reported the temperature-sensitive behavior according the nanostructure of gel. 
Because the fact that the crosslinker BIS reacts faster than VCL, a BIS rich core and a shell of VCL can be formed. 
According to this, at higher BIS concentration the core size increases resulting in NGs with higher sizes. This 
behavior can be observed for the two sets of experiment with different initial VCL concentrations. Besides, to the 
same BIS percentage (see PVCL804 and PVCL604), lower Dh values were obtained for lower initial concentra-
tion of VCL. This result could corroborate the presence of a core-shell structure in which the length of the shell 
decreases with the initial concentration of VCL.
Table 1 also shows that Tp decreases with the increase of BIS percentage, in agreement with previous work30. 
As it was mentioned previously, as BIS percentage increases, stronger intra-molecular interactions can be formed, 
for example hydrogen bonds between the amide groups of the BIS molecules. Accordingly, these hydrogen bonds 
behave as hydrophobic arrangements in which polymer–polymer interactions prevails on the polymer–water 
ones40. Consequently, the Tp decreases because the polymeric matrix interacts poorly with water molecules.
Figure 2. FT-IR spectra of PVCL NGs.
Figure 3. 1H-NMR spectra of VCL monomer and PVCL NG.
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The phase transition behavior was confirmed by UV-Vis-based turbidity experiments in which the cloud point 
temperature (Tcp), which represents the phase transition temperature (Tp), can be determined. Transmittance 
values were recorded at λ = 600 nm against temperature and resulted in a sharp transition between a narrow 
Figure 4. Average hydrodynamic diameters of the synthesized NGs as a function of the temperature of the 
medium.
Sample Dh* (nm) Tp (°C) Tcp (°C)
PVCL800 68 31.8 33.3
PVCL801 73 32.5 32.3
PVCL802 148 32.1 32.1
PVCL804 205 24.4 25.2
PVCL600 28 34.5 34.7
PVCL604 142 33.4 33.5
PVCL6010 164 31.9 32.6
Table 1. Average hydrodynamic diameters (Dh), phase transition temperatures (Tp) and cloud point 
temperatures (Tcp) of the synthesized NGs. *Dh measured in the swollen state below the transition phase 
temperature of the NGs.
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temperature range, which varied according amount of BIS in the NG, as shown in Table 1. As it can be seen, the 
values and trends of Tp and Tcp are similar.
Size and morphology of nanogels. To examine the size distribution and morphology of the NGs, TEM 
studies were performed. Figure 5 shows TEM images and size distribution corresponding to PVCL804 and 
PVCL600.
The TEM images reveal that the size was estimated up to about 40 and 50 nm, respectively, showing low poly-
dispersity in both cases and spherical shape of the particles.
The size values determined by DLS and TEM result similar for the case of the PVCL without BIS (PVCL600). 
However, the Dh value determined by DLS is higher than the one obtained from TEM for the crosslinked NG 
PVCL804. This fact can be due to the swelling in solution of the crosslinked NGs networks, this situation did not 
take place in the case of PVCL600 NGs due to the absence of crossing points and the poor hydrophilic character 
of VCL.
Figure 5. TEM images and size distribution of: PVCL804 (a,b) and PVCL600 (c,d).
Figure 6. TGA curves of synthetized NGs with different concentration of crosslinker.
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thermogravimetric analysis. Thermal behavior of the dried NGs was qualitatively investigated by ther-
mogravimetric analysis (Fig. 6). In the case of non-crosslinked NG (PVCL800), a single weight loss is observed 
around 460 °C corresponding to the PVCL decomposition, in accordance with previous reports41. For crosslinked 
nanogels (PVCL802 and PVCL804), thermograms show the beginning of thermal degradation at lower tempera-
tures (around 360 °C) and the major weight loss is similar to the observed for not-crosslinked NG.
Figure 7. Biocompatibility assays of PVCL804 NG. MTT assay was performed on TZM.bl cells after 48 h of 
PVCL804 exposure. TZM.bl cells were treated in range concentrations between 0.01 and 100 μg/mL. Medium 
alone (NTC) and DMSO were used as untreated and cell death controls, respectively. Data is presented as 
the mean ± SD of three individual experiments performed in triplicate. Abbreviations: NTC = non-treated 
control; DMSO = dimethyl sulfoxide.
Figure 8. Anti-HIV-1 activity of PVCL804 NG. TZM.bl cells were treated with PVCL804 at several non-toxic 
concentrations (10 µg/mL, 5 µg/mL and 1 µg/mL) or controls (G2-S16, 10 µM) for 1 h before infection with 
R5-HIV-1NLAD8 isolate (30 ng of p24/106 cells) for 2 h. The percentage of infection was determined at 48 h post-
infection by measuring luciferase activity (vs. CI). Data is presented as the mean ± SD of three independent 
experiments performed in triplicate. Abbreviations: CI = control of infection.
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Cytotoxic effect and antiviral properties of NGs. We tested PVCL804 NG as a potential candidate for 
its use in anti-HIV topical microbicide formulation because it has a collapsed ideal size at physiological tem-
perature. Accordingly, we first evaluated the toxicity of this NG in a cervicovaginal epithelial cell line by using a 
well-established metabolic activity assay (MTT).
A concentration range of PVCL804 NG (0.01 to 100 µg/mL) was tested for 48 h of exposure. Concentrations 
were considered non-toxic if the cellular viability was above 80% compared with non-treated control. The results 
show that PVCL804NG was non-toxic up to 10 µg/mL (Fig. 7). Above 10 μg/mL, a strong increase in toxicity can 
be observed. This may occur as a result of the increase in the size of the nanogel in the biological environment in 
which the assay was performed. Probably, this difference in size might be triggering cell death.
HIV-1 inhibition assays were carried out to determine the anti-HIV-1 efficacy of the PVCL804 NG. We selected 
the R5-HIV-1NLAD8 isolate because it is a widely used laboratory virus predominantly in the first steps of HIV-1 
infection42. PVCL804 NG showed an inhibitory effect against the R5-HIV-1 isolate in vitro since we obtained inhi-
bition rates >70% at the maximum non-toxic concentration (10 µg/mL) (Fig. 8). The ability to inhibit HIV-1 infec-
tion decreases as we reduce the concentration of the PVCL NG, exerting a dose-dependent effect.
Synthesized PVCL NGs cannot form anionic moieties which have been demonstrated to be important for 
antiviral activity43, therefore, its inhibitory effect should be due to the functional groups of the polymer matrix. 
These results support for the first time that PVCL NGs could be considered as candidates for a new HIV-1 micro-
bicide. Nevertheless, more studies are required to reveal the mechanisms involved in this inhibitory effect.
Conclusions
Thermo-responsive PVCL NGs were easily synthesized by thermo-precipitation in aqueous phase via free radical 
polymerization. Chemical structure of NGs was confirmed by FT-IR and 1H-NMR, the average sizes were deter-
mined by DLS and TEM, and thermo-responsive behavior was characterized by DLS and UV-Vis-based turbidity. 
Most of the NGs get agglomerated with the increase of temperature. However, the NG with initial concentration 
of 80 mg of VCL and 4% of BIS crosslinking agent (PVCL804 NG) collapses when it is heated. Therefore, this NG 
has a collapsed nanometric size at physiological temperature which is ideal for biomedical applications. Taking 
advantage of this thermal behavior, the cytotoxicity and antiviral effect of PVCL804 NG were tested. By using a 
well-established metabolic activity assay (MTT), it was determined that PVCL804 NG shows no cytotoxic effect 
at concentrations lower than 10 µg/mL in cervicovaginal epithelial cell line. Finally, we have demonstrated the 
antiviral effect of PVCL804 NG against the HIV-1 infection by quantification of luciferase activity. To the best of 
our knowledge, we report the first NG with in vitro inhibitory effect against the R5-HIV-1 by itself. Consequently, 
PVCL NGs could be considered as potential candidates for new HIV-1 microbicide formulations.
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